Evidence map›Paper›PMID 33680010›Full record

ArticleIranian journal of pharmaceutical research : IJPR2020

Fabrication and

Mahshid Arabi, Seyed Alireza Mortazavi, Zahra Jafariazar, Hassan Farhadnejad, Golnoosh Alipour Harisa, Yousef Fatahi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mahshid ArabiDepartment of Pharmaceutics, Faculty of Pharmacy, Islamic Azad University, Tehran, Iran.
Seyed Alireza MortazaviDepartment of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zahra JafariazarDepartment of Pharmaceutics, Faculty of Pharmacy, Islamic Azad University, Tehran, Iran.
Hassan FarhadnejadStudent Research Committee, Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Golnoosh Alipour HarisaDepartment of Pharmaceutics, Faculty of Pharmacy, Islamic Azad University, Tehran, Iran.
Yousef FatahiDepartment of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, buccal mucoadhesive tablets of meloxicam were formulated for drug delivery as an alternative route. Direct compression method was applied for the preparation of tablets. Also, different polymers, including hydroxypropyl methyl cellulose (HPMC) 1000, 4000, and 10000, as well as carbopol 934p and carbopol 971p were used as the mucoadhesive polymer and retardant polymer. Thirteen formulations were investigated with various concentrations of polymers. The physicochemical characteristics,

Indexed as

Buccal tabletCarbopolDrug deliveryHPMCMeloxicamMucoadhesive

Identifiers

PMID33680010
PMCPMC7758005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.